<DOC>
	<DOCNO>NCT02249975</DOCNO>
	<brief_summary>The purpose study assess efficacy performance C2 Focal Cryoablation System patient BE .</brief_summary>
	<brief_title>Efficacy CryoBalloon Focal Ablation System Human Esophageal Barrett 's Epithelium</brief_title>
	<detailed_description>The purpose study assess efficacy performance C2 Focal Cryoablation System patient BE . The study involve 50 subject subject receive cryoablation therapy visible BE use C2 System Focal Ablation System . Length ablation 10 second . The ablation perform Barrett 's epithelium maximal length 6 cm . At time endoscopic follow , biopsy treat area take submit analysis accord Histopathology Protocol . This study : - Prospective - Multi-center - Non-randomized</detailed_description>
	<mesh_term>Barrett Esophagus</mesh_term>
	<criteria>Criteria Inclusion Criteria Patients know Barrett 's esophagus , indication ablation therapy cryoablation may perform . Patient 18 80 year age time consent ( inclusive ) . Patient provide write Informed Consent ( IC ) use Informed Consent Form ( ICF ) approve Institution 's review IRB/EC . Patient willing able comply Clinical Investigation Plan ( CIP ) requirement . Patient deem operable per standard institutional criterion . BE lesion length &lt; 6cm exclude visible BE island , Prague Classification C ≥ 0 / M ≥ 0 . One following : Flat LGD , Flat HGD , Residual BE EMR visible lesion ( contain degree dysplasia lowrisk early adenocarcinoma ( i.e . : poorly differentiate , negative vertical ( deep ) resection margin , absence ( lympho ) vascular invasion ) , Residual BE single circumferential RFA ( perform indication list : iiii ) BE lesion within treatment zone flat Exclusion Criteria Esophageal stenosis prevent advancement therapeutic endoscope within 4 cm treatment zone . Patient known history unresolved drug alcohol dependency would limit ability comprehend follow instruction relate informed consent , post treatment instruction followup guideline . Patient refuse unable provide write informed consent . Patients pregnant . Patient endoscopically active inflammation treatment zone . Endoscopically visible abnormality mass nodule require endoscopic resection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>